EdgeMarket › Instruments › PTHS

PTHS — Pelthos Therapeutics Inc.

Name: PTHS — Pelthos Therapeutics Inc. market data and filings
Creator: EdgeMarket

US Healthcare Pharma & biotech equity mkt cap 102.1M

25.51 -4.31% today

USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown

52w low 18.19 · high 37.42

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2024-02-16.

Performance

1 day-4.31%

1 week-7.24%

1 month-10.18%

3 months-5.87%

6 months+9.77%

Year to date-13.38%

1 year+19.15%

Technicals

RSI 1443.9

vs 50-day avg-6.83%

vs 200-day avg-1.43%

Volatility 1y84.2%

Max drawdown 1y-51.39%

Avg volume 30d79.7K

Daily bars held630

History from2024-02-16

Others in Healthcare

LLY +0.9%AKTX +1.6%JNJ +1.1%ONC +1.5%ABBV +1.2%MRK +2.4%UNH +1.4%NVS +1.7%

Insider transactions (Form 4)

date	insider	what	shares	price	value
2026-07-02	Greenleaf Peter Director	Open-market sale 10b5-1 plan	712	26.00	18.5K
2026-07-02	Pauls Matthew Director	Open-market sale 10b5-1 plan	692	26.00	18.0K
2026-07-02	Friedberg Ezra M Director	Open-market sale 10b5-1 plan	534	26.03	13.9K
2026-07-02	Pauls Matthew Director	Open-market sale 10b5-1 plan	94	27.36	2.6K
2026-07-02	Greenleaf Peter Director	Open-market sale 10b5-1 plan	85	27.27	2.3K
2026-07-02	Friedberg Ezra M Director	Open-market sale 10b5-1 plan	24	27.33	656
2026-06-15	Friedberg Ezra M Director	Open-market sale 10b5-1 plan	224	27.12	6.1K
2026-06-15	Friedberg Ezra M Director	Open-market sale 10b5-1 plan	59	27.94	1.6K
2026-06-11	Davis Todd C Director	Open-market purchase	35.4K	27.80	985.5K
2026-06-11	Davis Todd C Director	Open-market purchase	503	28.73	14.4K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

manager	value	shares
Murchinson Ltd.	6.2M	296.3K
Ikarian Capital, LLC	5.4M	256.6K
VANGUARD CAPITAL MANAGEMENT LLC	2.0M	93.1K
BOOTHBAY FUND MANAGEMENT, LLC	1.7M	81.9K
J. Goldman & Co LP	1.1M	50.4K
CANTOR FITZGERALD, L. P.	870.3K	41.4K
DIADEMA PARTNERS LP	520.5K	24.8K
Knott David M Jr	442.7K	21.1K
GEODE CAPITAL MANAGEMENT, LLC	321.2K	15.3K
Pale Fire Capital SE	271.4K	12.9K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d54.9% of tape

Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Pelthos Therapeutics GAAP EPS of -$6.62 misses by $3.72, revenue of $15.6M beats by $0.38M · 2026-08-13
Pelthos Therapeutics Inc. (PTHS) filed form 8-K · 2026-08-13 · SEC EDGAR
Pelthos Therapeutics Inc. (PTHS) filed form 8-K · 2026-08-13 · SEC EDGAR

Ask the AI about PTHS

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open PTHS in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Create a free account Open the terminal first

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →